Vantage logo

A radical strategy for Medtronic

The sellside expects the world’s leading medtech to be outpaced by its rivals. Divestments might allow the group to defy this destiny.

Vantage logo

A beautiful autumn for Covid-19 test makers

Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.

Vantage logo

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.